|
Age
|
46.9 ± 14.5
|
63.6 ± 10.9
|
< 0.001
|
|
Gender, male %
|
63.5
|
78.8
|
0.10
|
|
Time of follow up, months
|
106 (101–111)
|
76 (64–85)
|
< 0.001
|
|
Dialysis vintage, months ǂ
|
7 (4–15)
|
9 (3–23)
|
0.32
|
|
Peritoneal dialysis, %
|
23
|
15
|
0.31
|
|
Waitlisted for RTX, %
|
68
|
60
|
0.40
|
|
Living donor, %
|
29
|
17
|
0.17
|
|
Hypertension, %
|
89
|
85
|
0.58
|
|
Cardiovascular disease, %
|
11
|
31
|
0.005
|
|
Charlson comorbidity index
|
4 (2–6)
|
6 (5–7)
|
0.001
|
|
Diabetes, %
|
23
|
15
|
0.32
|
|
Body mass index, kg/m2
|
25.4 ± 4.4
|
25.7 ± 4.2
|
0.52
|
|
Systolic blood pressure, mmHg
|
140 ± 20
|
148 ± 18
|
0.02
|
|
Diastolic blood pressure, mmHg
|
81 ± 12
|
76 ± 10
|
0.05
|
|
Haemoglobin, g/dL
|
12.3 ± 1.5
|
12.1 ± 1.4
|
0.30
|
|
Albumin, mmol/L
|
39 (38–42)
|
41 (37–43)
|
0.53
|
|
Cause of end stage renal disease, %
|
|
-Diabetic nephropathy
|
15
|
0
|
0.02
|
|
-Nephrosclerosis
|
14
|
32
|
0.02
|
|
-Glomerulonephritis
|
33
|
21
|
0.52
|
|
-Inherited cystic kidney disease
|
10
|
18
|
0.28
|
|
-Other
|
27
|
29
|
0.82
|
